Amino acid replacement: Q1310term.
C5176178T
Q1141term | cno-PC; Q1310term | cno-PE; Q980term | cno-PF; Q1210term | cno-PG; Q1227term | cno-PH; Q1310term | cno-PJ
Q1310term
Site and nature of nucleotide substitution in mutant inferred by FlyBase curator based on reported amino acid change.
embryo | embryonic stage 14 (with cnomis1)
cno2/+ heterozygous embryos do not display significant increase in the number of hemisegments with abnormal number of neurons in the RP2 lineage compared to wild-type.
54% of cno2/cnomis1 embryos hatch, 23% have their cuticle closed dorsally (with 16% having a head involution defect), 22% have the cuticle partially open and 1% have a large dorsal hole in the cuticle (covering at least half of the dorsal aspect). cno2 embryos show defects ranging from small anterior holes in the cuticle (19%) to large holes covering almost the entire dorsal aspect of the embryo (81%). The leading edge cytoskeleton is assembled largely as in wild-type embryos and an initial stretching of the lateral ectodermal cells takes place during the dorsal closure stage in cno2 embryos. However, at later stages of dorsal closure, the mutant embryos show a detachment of the lateral ectoderm from the amnioserosa; the ectoderm retracts, with the cells resuming a non-elongated shape and the amnioserosa shrivels.
strongest allele
cnomis1/cno2 has increased mortality during development phenotype, enhanceable by PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 has abnormal cell migration | embryonic stage phenotype, enhanceable by PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 has increased mortality during development phenotype, enhanceable by zip2/zipEbr
cnomis1/cno2 has abnormal cell migration | embryonic stage phenotype, enhanceable by zip2/zipEbr
cnomis1/cno2 has increased mortality during development phenotype, enhanceable by PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 has abnormal cell migration | embryonic stage phenotype, enhanceable by PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 has some die during embryonic stage phenotype, enhanceable by Rap1CD5/Rap1CD5
cno2 has abnormal cell migration | embryonic stage phenotype, non-enhanceable by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has abnormal cell migration | embryonic stage phenotype, non-enhanceable by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has lethal | embryonic stage phenotype, suppressible by Scer\GAL4ptc-559.1/bskUAS.cBa
cno2 has lethal - all die during embryonic stage phenotype, non-suppressible by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has lethal - all die during embryonic stage phenotype, non-suppressible by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has abnormal cell migration | embryonic stage phenotype, non-suppressible by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has abnormal cell migration | embryonic stage phenotype, non-suppressible by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has lethal | embryonic stage phenotype, non-suppressible by Scer\GAL4ptc-559.1/Rap1V12.UAS.Tag:MYC
cnomis1/cno2 is an enhancer of increased mortality during development phenotype of PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 is an enhancer of increased mortality during development phenotype of PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 is an enhancer of increased mortality during development phenotype of zip2/zipEbr
cno2 is an enhancer of abnormal cell polarity phenotype of S48-5
cno2, wtsx1/wts[+] has abnormal neuroanatomy | embryonic stage phenotype
cno2, ex1/ex[+] has abnormal neuroanatomy | embryonic stage phenotype
Mer[+]/Mer4, cno2 has abnormal neuroanatomy | embryonic stage phenotype
cno2, matse03077/mats[+] has abnormal neuroanatomy | embryonic stage phenotype
cno2, sav[+]/sav3 has abnormal neuroanatomy | embryonic stage phenotype
cno2, yki[+]/ykiB5 has abnormal neuroanatomy | embryonic stage phenotype
cno2, ftG-rv/ft[+] has abnormal neuroanatomy | embryonic stage phenotype
cnomis1/cno2, zipEbr has visible | adult stage phenotype
cnomis1/cno2 has ommatidium phenotype, enhanceable by ed[+]/ed1X5
cnomis1/cno2 has ectoderm | embryonic stage phenotype, enhanceable by PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 has embryo phenotype, enhanceable by PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 has ectoderm | embryonic stage phenotype, enhanceable by PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, enhanceable by PDZ-GEFk13720/PDZ-GEFC2
cnomis1/cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, enhanceable by zip2/zipEbr
cnomis1/cno2 has embryo phenotype, enhanceable by PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, enhanceable by PDZ-GEFC1/PDZ-GEFk13720
cno2 has embryo phenotype, non-enhanceable by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, non-enhanceable by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has ectoderm | embryonic stage phenotype, non-enhanceable by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has embryo phenotype, non-enhanceable by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, non-enhanceable by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has ectoderm | embryonic stage phenotype, non-enhanceable by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cnomis1/cno2 has ommatidium phenotype, non-enhanceable by fafFO8/faf[+]
cnomis1/cno2 has ommatidium phenotype, suppressible by fred[+]/fredH24
cno2 has embryo | dorsal closure stage phenotype, suppressible by Scer\GAL4ptc-559.1/bskUAS.cBa
cno2 has embryo phenotype, non-suppressible by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, non-suppressible by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has ectoderm | embryonic stage phenotype, non-suppressible by Scer\GAL4VP16.PDZ-GEF/PDZ-GEFUAS.cBa
cno2 has embryo phenotype, non-suppressible by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has embryonic/first instar larval cuticle | embryonic stage phenotype, non-suppressible by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has ectoderm | embryonic stage phenotype, non-suppressible by PDZ-GEFUAS.Tag:Myr(Src42A)/Scer\GAL4VP16.PDZ-GEF
cno2 has embryo | dorsal closure stage phenotype, non-suppressible by Scer\GAL4ptc-559.1/Rap1V12.UAS.Tag:MYC
cnomis1/cno2 is an enhancer of embryo phenotype of PDZ-GEFC1/PDZ-GEFk13720
cnomis1/cno2 is an enhancer of embryo phenotype of PDZ-GEFk13720/PDZ-GEFC2
cno2 is an enhancer of ommatidium phenotype of S48-5
cno2/cno[+] is a non-enhancer of ommatidium phenotype of fafFO8/fafBX3
cno2 is a suppressor | partially of wing phenotype of PDZ-GEFUAS.EGFP, Scer\GAL4en.PU
cno2 is a suppressor | partially of wing vein L2 phenotype of PDZ-GEFUAS.EGFP, Scer\GAL4en.PU
cno2 is a suppressor | partially of wing vein L3 phenotype of PDZ-GEFUAS.EGFP, Scer\GAL4en.PU
cno2, wtsx1/wts[+] has larval RP2 motor neuron | embryonic stage phenotype
cno2, ex1/ex[+] has larval RP2 motor neuron | embryonic stage phenotype
Mer[+]/Mer4, cno2 has larval RP2 motor neuron | embryonic stage phenotype
cno2, matse03077/mats[+] has larval RP2 motor neuron | embryonic stage phenotype
cno2, sav[+]/sav3 has larval RP2 motor neuron | embryonic stage phenotype
cno2, yki[+]/ykiB5 has larval RP2 motor neuron | embryonic stage phenotype
cno2, ftG-rv/ft[+] has larval RP2 motor neuron | embryonic stage phenotype
The proportion of hemisegments with abnormal number of neurons in the asymmetrically dividing RP2 neural lineage is significantly increased in embryos that are double heterozygous for cno2 and any of the following: wtsx1, matse03077, sav3, ykiB5, ftG-rv, ex1 or Mer4. No such significant increase is observed in embryos double heterozygous for cno2 and hpoKC202.
Homozygosity for RCD5 enhances the cno2/cnomis1 phenotype; only 4% of cnomis1 RCD5/cno2 RCD5 double mutant embryos develop into larvae or have a completely closed cuticle, 37% have large anterior holes in the cuticle and 59% are completely open dorsally. The dorsal closure defects seen in cno2 embryos are not rescued by co-expression of expressing RV12.Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4ptc-559.1. Expression of bskScer\UAS.cBa under the control of Scer\GAL4ptc-559.1 results in a significant but partial rescue of the dorsal closure defects seen in cno2 embryos.
cno2 is partially rescued by Scer\GAL4ptc-559.1/cnoRA1mut+RA2mut.UAS
cno2 is partially rescued by Scer\GAL4ptc-559.1/cnoΔN.UAS
cno2 is partially rescued by Scer\GAL4ptc-559.1/cnoUAS.cBa